Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of Umbilical Cord Mesenchymal Stem Cells and Liraglutide for Type 2 diabetes; the current status is not di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells
• liraglutide (liraglutide)

Snippet

Sponsor: Diabetes Care Center of Nanjing Military Command | Conditions: Type 2 Diabetes | Phase 1, Phase 2 | Status: UNKNOWN